Skip to content
POM-V Prescription Required Companion Animal

Enrocat Flavour 25 mg/ml Oral Suspension for Cats

Active ingredient: Enrofloxacin

Form

Liquid

Species

Cats

Manufacturer

Industrial Veterinaria SA

VMD MA No.

36547/3014

What it's used for

Pigs: For the treatment of bacterial bronchopneumonia caused by enrofloxacin-susceptible Actinobacillus pleuropneumoniae, Pasteurella multocida and complic...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Enrofloxacin

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Enrocat Flavour 25 mg/ml Oral Suspension for Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Pigs:
For the treatment of bacterial bronchopneumonia caused by enrofloxacin-susceptible
Actinobacillus pleuropneumoniae, Pasteurella multocida and complicated by
Haemophilus parasuis as secondary pathogen in pigs.
The veterinary medicinal product should be administered directly onto the back of the
tongue and not in the animal’s feed.
The dosage is 5 mg enrofloxacin per kg bodyweight once daily for 5 consecutive
days. This is equivalent to 0.2 ml of the veterinary medicinal product per kg
bodyweight once daily for 5 consecutive days.
In chronic and severe diseases, the duration of treatment can be extended up to 10
days.
Treatment should be reconsidered if no improvement of the condition is observed
after 3 days of treatment.
To ensure a correct dosage, body weight should be determined as accurately as
possible.
Do not exceed the recommended dosage.
Figure 1: Administration of the veterinary medicinal product

Shake well for 15
seconds before use
Draw out the
appropriate dosage
into the syringe
Administer directly
onto the back of
the tongue
In order to avoid cross-contamination, the same syringe should not be used for
different animals. Thus, one syringe should only be used for one animal. After
administration the syringe should be cleaned with tap water and stored in the carton
box together with the veterinary medicinal product.
A 3 ml syringe with 0.1 ml graduations is supplied with every package of the
veterinary medicinal product.
Do not use in animals with existing impairment of cartilage growth.
Do not use in animals with a known history of seizuressince enrofloxacin may cause
CNS stimulation.
Do not use in cases of hypersensitivity to the active substance or other
fluoroquinolones or to any of the excipients.
Do not use in animals less than 8 weeks of age.
AN: 01484/2025 & 01485/2025
Cats
Very rare
(<1 animal / 10 000 animals
treated, including isolated
reports):
Digestive tract disorders (e.g. hypersalivation,
vomiting or diarrhoea)
Anorexia
Anaphylaxis
Neurological disorders (e.g. ataxia, seizure,
tremor)
Excitation
Undetermined frequency
(cannot be estimated from the
available data):
Hypersensitivity reaction
Mild and transient.
As a result of digestive tract disorders.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
None.

Special precautions for safe use in the target species:
Fluoroquinolones should be reserved for the treatment of clinical conditions which
have responded poorly, or are expected to respond poorly, to other classes of
antimicrobials.
Whenever possible, fluoroquinolones should only be used based on susceptibility
testing.
Use of the veterinary medicinal product deviating from instructions given in the SPC
may increase the prevalence of bacteria resistant to fluoroquinolones and may
decrease the effectiveness of treatment with other quinolones due to the potential for
cross resistance.
Official and local antimicrobial policies should be taken into account when the
veterinary medicinal product is used.
In cases of pyoderma, possible underlying primary disease should be identified and
treated.
Enrofloxacin is partially excreted via the kidneys; as with all fluoroquinolones,
excretion may therefore be delayed in individuals with existing renal damage.
The veterinary medicinal product should be used with caution in animals with severe
renal or hepatic impairment.
Retinotoxic effects including blindness can occur when the recommended dose is
exceeded.
Do not use in cases of known resistance to quinolones or fluoroquinolones because
of near-total cross-resistance to the former and complete cross-resistance to the
latter.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Enrofloxacin and sorbic acid may cause hypersensitivity (allergic reactions). People
with known hypersensitivity to enrofloxacin or to any of the excipients should avoid
contact with the veterinary medicinal product.
The veterinary medicinal product may be irritant to skin and eyes.
Avoid dermal and eye contact with the veterinary medicinal product. In case of
accidental dermal and/or eye contact, wash any splashes from skin or eyes
immediately with water.
Enrofloxacin may cause gastrointestinal effects such as abdominal pain and
diarrhoea if ingested. To avoid accidental ingestion, particularly by a child, do not
leave a syringe containing the solution in the sight or reach of children. The used
syringe should be stored with the veterinary medicinal product in the original carton.
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
Do not eat, drink or smoke while handling the veterinary medicinal product.
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.
AN: 01484/2025 & 01485/2025
Combination of the veterinary medicinal product (enrofloxacin) with chloramphenicol,
macrolide antibiotics or tetracyclines may produce antagonistic effects.
The concomitant administration of substances containing magnesium or aluminium
may reduce the absorption of enrofloxacin. These drugs should be administered two
hours apart.
Concomitant administration of theophylline requires careful monitoring as serum
levels of theophylline may increase.
The concomitant use with digoxin should be avoided as fluoroquinolones can
increase the bioavailability of digoxin.
Concurrent administration of fluoroquinolones may increase the action of oral
anticoagulants.
Concomitant administration of fluoroquinolones in combination with non-steroidal
anti-inflammatory drugs (NSAID) in animals could lead to seizures because of
potential pharmacodynamic interactions in the CNS.
In animals subjected to rehydration, avoid excessive alkalinity of the urine.
AN: 01484/2025 & 01485/2025
This veterinary medicinal product does not require any special storage conditions.
Not applicable.
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.